Exploring design trade-offs for achieving social inclusion in multi-tiered design problems

ABSTRACT

The digital age of the future is ‘not out there to be discovered’, but it needs to be ‘designed’. The design challenge has to address questions about how we want to live, work, and learn (as individuals and as communities) and what we value and appreciate, e.g.: reflecting on quality of life and creating inclusive societies. An overriding design trade-off for the digital age is whether new developments will increase the digital divide or will create more inclusive societies. Sustaining inclusive societies means allowing people of all ages and all abilities to exploit information technologies for personally meaningful activities. Meta-design fosters the design of socio-technical environments that end-user developers can modify and evolve at use time to improve their quality of life and favour their inclusion in the society. This paper describes three case studies in the domain of assistive technologies in which end users themselves cannot act as end-user developers, but someone else (e.g.: a caregiver or a clinician) must accept this role requiring multi-tiered architectures. The design trade-offs and requirements for meta-design identified in the context of the case studies and other researchers’ projects are described to inform the development of future socio-technical environments focused on social inclusion.     

Efficient wavelength conversion with high-power passivelyQ-switched diode-pumped neodymium lasers

Powerful CW diode-pumped Nd:YAG and Nd:YVO4 lasers Q-switched by Cr:YAG saturable absorbers demonstrate efficient (30%-60%) harmonic and parametric conversion, generating hundreds of milliwatts from ultraviolet to mid-infrared     

Rule-based tools for the configuration of ambient intelligence systems: a comparative user study

Multimedia Tools and Applications - This paper describes a 63-participant user study that compares two widely known systems supporting end users in creating trigger-action rules for the Internet of...     

Validation of a Lab-on-Chip Assay for Measuring Sorafenib Effectiveness on HCC Cell Proliferation

Hepatocellular carcinoma (HCC) is a highly lethal cancer, and although a few drugs are available for treatment, therapeutic effectiveness is still unsatisfactory. New drugs are urgently needed for hepatocellular carcinoma (HCC) patients. In this context, reliable preclinical assays are of paramount importance to screen the effectiveness of new drugs and, in particular, measure their effects on HCC cell proliferation. However, cell proliferation measurement is a time-consuming and operator-dependent procedure. The aim of this study was to validate an engineered miniaturized on-chip platform for real-time, non-destructive cell proliferation assays and drug screening. The effectiveness of Sorafenib, the first-line drug mainly used for patients with advanced HCC, was tested in parallel, comparing the gold standard 96-well-plate assay and our new lab-on-chip platform. Results from the lab-on-chip are consistent in intra-assay replicates and comparable to the output of standard crystal violet proliferation assays for assessing Sorafenib effectiveness on HCC cell proliferation. The miniaturized platform presents several advantages in terms of lesser reagents consumption, operator time, and costs, as well as overcoming a number of technical and operator-dependent pitfalls. Moreover, the number of cells required is lower, a relevant issue when primary cell cultures are used. In conclusion, the availability of inexpensive on-chip assays can speed up drug development, especially by using patient-derived samples to take into account disease heterogeneity and patient-specific characteristics.     

Diode-pumped neodymium lasers repetitively Q-switched by Cr4+:YAG solid-state saturable absorbers

We report on the experimental results of a continuously diode-laser pumped Nd:YAG laser, operating at 1064 nm and repetitively Q-switched by a Cr⁴⁺:YAG solid-state saturable absorber. End-pumping the Nd:YAG with a 10-W fiber-coupled diode-laser we could either optimize the energy or the average output power, depending on the choice of the saturable absorber and the output coupler. The maximum energy was ≈200 μJ in single TEM₀₀, 17 ns pulses at 6 kHz, whereas a maximum average power of ≈2 W with 32-ns pulses at 20 kHz was obtained. We also present preliminary results of a repetitively Q-switched Nd:YVO₄ laser at 1064 nm. The repetitive Q-switching operation is described by an improved model, which accounts for the behavior of both the active medium and the solid-state saturable absorber. The results of the model agree fairly well with the experimental data. Experimental results of second harmonic conversion are also reported and interpreted using a depleted pump model     

End users as co-designers of their own tools and products

In our Age of exponential technological advance, recent developments are determining an evolution of end users from passive information consumers into information producers. Users are increasingly willing and, indeed, determined to shape the software they use to tailor it to their own needs. Based on a brief review of research activities we performed in the last decade, this paper analyzes some challenges that software designers face to comply with the new roles of end users in the software life cycle, and discusses how to provide end users with software environments that empower them to become co-designers of their own tools and products. The examples reported in the paper show why and how end users are involved in design activities in various application domains.     

A Novel Genetic Variant in the WFS1 Gene in a Patient with Partial Uniparental Mero-Isodisomy of Chromosome 4

Wolfram syndrome is a rare autosomal recessive disorder characterized by optic atrophy and diabetes mellitus. Wolfram syndrome type 1 (WFS1) is caused by bi-allelic pathogenic variations in the wolframin gene. We described the first case of WFS1 due to a maternal inherited mutation with uniparental mero-isodisomy of chromosome 4. Diabetes mellitus was diagnosed at 11 years of age, with negative anti-beta cells antibodies. Blood glucose control was optimal with low insulin requirement. No pathogenic variations in the most frequent gene causative of maturity-onset diabetes of the young subtypes were detected. At 17.8 years old, a rapid reduction in visual acuity occurred. Genetic testing revealed the novel homozygous variant c.1369A>G; p.Arg457Gly in the exon 8 of wolframin gene. It was detected in a heterozygous state only in the mother while the father showed a wild type sequence. In silico disease causing predictions performed by Polyphen2 classified it as “likely damaging”, while Mutation Tester and Sift suggested it was “polymorphism” and “tolerated”, respectively. High resolution SNP-array analysis was suggestive of segmental uniparental disomy on chromosome 4. In conclusion, to the best of our knowledge, we describe the first patient with partial uniparental mero-isodisomy of chromosome 4 carrying a novel mutation in the wolframin gene. The clinical phenotype observed in the patient and the analysis performed suggest that the genetic variant detected is pathogenetic.     

Dependence of rotational and vibrational Raman scattering onfocusing geometry

Stimulated rotational and vibrational Raman scattering in H₂ was investigated with a circularly and a linearly polarized XeCl laser beam and the influence of the focusing geometry on the threshold for rotational and vibrational scattering, respectively, was studied. It is shown that with a circularly polarized pump beam a high-angle focusing geometry allows to get only rotational Raman scattering, whereas a low-angle focusing geometry provides only vibrational Raman scattering for gain suppression effects     

The Increase of miR-195-5p Reduces Intestinal Permeability in Ulcerative Colitis,Modulating Tight Junctions’ Expression

Defects in the intestinal epithelial barrier functions characterize inflammatory conditions such as Inflammatory Bowel Disease (IBD). Overexpression of pro-inflammatory cytokines such as TNF-α, IL-1B, IL-6 and INF-γ trigger epithelial damage. These cytokines are due to upregulation of claudin-2 (CLDN2) that form a pore channel, resulting in redistribution of TJs and an alteration of barrier permeability. Recently, we demonstrated that miR-195-5p is able to regulate CLDN2 and indirectly also CLDN1 in intestinal epithelial cells. Now, we aimed to investigate the modulation of miR-195-5p on the expression of CLDN2 and other TJs under inflammatory conditions induced by TNF-α. We demonstrated that miR-195-5p also modulated the expression of CLDN2 levels after stimulation with TNF-α. In addition, we discovered the role of miR-195-5p in the integrity of the intestinal barrier and in promoting the restoration of the intestinal epithelial. Moreover, we established that replacement of miR-195-5p attenuated the colonic inflammatory response in DSS-induced, colitis and it reduced colonic permeability. In conclusion, our data revealed the role of miR-195-5p in intestinal inflammation in ulcerative colitis, suggesting a potential pharmacological target for new therapeutic approaches.